Cargando…

What Can We Save for the First-Line Treatment of NSCLC in 2016?

Detalles Bibliográficos
Autor principal:	Rossi, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649993/ https://www.ncbi.nlm.nih.gov/pubmed/29147431 http://dx.doi.org/10.14740/wjon1017w

Ejemplares similares

What Can We Do to Be Saved?
por: Visanska, Samuel A.
Publicado: (1913)

Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
por: Gravara, Luigi Della, et al.
Publicado: (2020)

Sustainability in Orthodontics: what can we do to save our planet?
por: Pithon, Matheus Melo, et al.
Publicado: (2017)

Are We Saving at the Spigot and Wasting at the Bung?
Publicado: (1916)

Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?
por: Bahl, A, et al.
Publicado: (2001)

What Shall We Do to Be Saved
por: Belcher, Wm. W.
Publicado: (1912)

Surgery: To what extent can we operate?
por: Kakeji, Yoshihiro
Publicado: (2018)

Can we more efficiently save patients with vitamin K-dependent coagulopathy caused by superwarfarin intoxication?
por: Park, Jinny
Publicado: (2014)

We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020)

How biomanufacturing can save the world
Publicado: (2021)

Outcome after CPR: when we cannot save lives, we can save organs
por: Caestecker, C, et al.
Publicado: (2015)

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

Racism in science: what can we do about it?
Publicado: (2020)

The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)

Can Leveraging Technology “Save” Physical Therapy?
por: Gobezie, Reuben
Publicado: (2023)

Six lessons from first year COVID-19 restrictions: what can we do better in the future?
por: Susilo, Yusak, et al.
Publicado: (2021)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

What Do We Know about Suicide Bereavement, and What We Can Do to Help Suicide-Loss Survivors?
por: Levi-Belz, Yossi, et al.
Publicado: (2023)

What can we offer to 3 million MDRTB household contacts in 2016?
por: Moore, David A. J.
Publicado: (2016)

Publication of clinical trial protocols – what can we learn?
por: Skogvoll, Eirik, et al.
Publicado: (2013)

Neuroblastoma Mass Screening—What Can We Learn From It?
por: Katanoda, Kota
Publicado: (2016)

Obesity and weight management: What can we do as gastroenterologists?
por: Wang, Xia-Qing, et al.
Publicado: (2020)

Gender disparity in scientific publishing: What can we do?
Publicado: (2020)

First-line immune-chemotherapy combination for squamous NSCLC is already a reality
por: Hendriks, Lizza E. L., et al.
Publicado: (2020)

First Latin uterine transplantation: we can do it!
por: Soares, José Maria, et al.
Publicado: (2016)

Cervicofacial Flap: Can We Save Patient's Sideburns?
por: Lim, Dong Seob, et al.
Publicado: (2017)

More Evidence on the Effects of Deworming: What Lessons Can We Learn?
por: Croke, Kevin, et al.
Publicado: (2017)

Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
por: Kaufmann, Horacio
Publicado: (2017)

Editorial: Clustering of Schizophrenia With Other Comorbidities—What Can We Learn?
por: Mitchell, Braxton D.
Publicado: (2009)

Screening Mammography: What Good Is It and How Can We Know If It Works?
por: Vannier, Michael W.
Publicado: (2012)

What is “moral distress” in nursing? How, can and should we respond to it?
por: Morley, Georgina
Publicado: (2018)

Modelling Covid-19 under uncertainty: what can we expect?
por: Wang, Meimei, et al.
Publicado: (2020)

A broader look at Interceptive Orthodontics: What can we offer?
por: Artese, Flavia
Publicado: (2019)

Intervention of Particulate Matter: What Can We Do for Asthmatic Patients?
por: Ahn, Kangmo
Publicado: (2021)

Tackling cisplatin resistance in ovarian cancer: what can we do?
por: Perego, Paola
Publicado: (2021)

Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't
por: Ong, Albert C M, et al.
Publicado: (2022)

First-line management of advanced non-small-cell lung cancer: can we do better?
por: Chouaïd, Christos, et al.
Publicado: (2023)

Individualized Treatment Effects: Machine Learning Can Revolutionize Observations, but Let’s Understand What We Are Observing
por: Mosier, Jarrod M.
Publicado: (2023)

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
por: Cagnazzo, Celeste, et al.
Publicado: (2020)

Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?
por: Pfeiffer, Per, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1vrunb0ods9e3uqt8u1bcrtvss